Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1304945

C1=Cc2nc1c(-c1ccccc1)c1ccc([nH]1)c(-c1ccccc1)c1nc(c(-c3ccccc3)c3ccc([nH]3)c2-c2ccccc2)C=C1.Cl.Cl.[SiH4]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TOP1 known ✓ P11387 4/20 0.60
▸ STAT3 P40763 1/20 0.59
▸ STAT1 P42224 1/20 0.59
▸ CYCS P99999 3/20 0.58
▸ TERT O14746 4/20 0.57
▸ ENPP2 Q13822 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8014524 0.98 TOP1 (0.62) TOP1STAT3STAT1CYCSTERT
SCHEMBL8014529 0.98 TOP1 (0.62) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL31677406 0.98 TOP1 (0.62) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL7157353 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL5572880 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL483549 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL599424 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL483748 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL1465442 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT
Hydrochloric Acid SCHEMBL483503 0.96 TOP1 (0.60) TOP1STAT3STAT1CYCSTERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8057918-B2 Organic light-emitting diodes and methods for assembly and enhanced charge injection NORTHWESTERN UNIVERSITY (US) 2011-11-15 — — US disclosed
US-8053094-B2 Organic light-emitting diodes and methods for assembly and enhanced charge injection NORTHWESTERN UNIVERSITY (US) 2011-11-08 — — US disclosed
US-7969088-B2 Method of using silicon molecular components for controlling charge migration and light emission of organic light-emitting diodes NORTHWESTERN UNIVERSITY (US) 2011-06-28 — — US disclosed
US-7750175-B2 Organic light-emitting diodes and related hole transport compounds NORTHWESTERN UNIVERSITY (US) 2010-07-06 — — US disclosed
US-20090284145-A1 Organic Light-Emitting Diodes and Methods for Assembly and Enhanced Charge Injection NATIONAL SCIENCE FOUNDATION 2009-11-19 — — US disclosed
US-20090284137-A1 ORGANIC LIGHT-EMITTING DIODES AND METHODS FOR ASSEMBLY AND EMISSION CONTROL NORTHWESTERN UNIVERSITY 2009-11-19 — — US disclosed
US-20090224657-A1 ORGANIC LIGHT-EMITTING DIODES AND METHODS FOR ASSEMBLY AND ENHANCED CHARGE INJECTION MARKS TOBIN J 2009-09-10 — — US disclosed
US-20070170844-A1 Organic light-emitting diodes and methods for assembly and emission control NORTHWESTERN UNIVERSITY 2007-07-26 — — US disclosed
WO-2006023950-A2 ORGANIC LIGHT-EMITTING DIODES AND RELATED HOLE TRANSPORT COMPOUNDS NORTHWESTERN UNIVERSITY (US) 2006-03-02 — — WO disclosed
US-20050260443-A1 Organic light - emitting diodes and methods for assembly and enhanced charge injection MARKS TOBIN J 2005-11-24 — — US disclosed
US-20050234256-A1 Organic light-emitting diodes and related hole transport compounds NATIONAL SCIENCE FOUNDATION 2005-10-20 — — US disclosed
US-6939625-B2 Organic light-emitting diodes and methods for assembly and enhanced charge injection Nôrthwestern University (US) 2005-09-06 — — US disclosed
US-20050158579-A1 Organic light-emitting diodes and methods for assembly and enhanced charge injection NATIONAL SCIENCE FOUNDATION 2005-07-21 — — US disclosed
US-20040092195-A1 Organic light-emitting diodes and methods for assembly and emission control NATIONAL SCIENCE FOUNDATION 2004-05-13 — — US disclosed
US-20030162053-A1 Organic light - emitting diodes and methods for assembly and enhanced charge injection NATIONAL SCIENCE FOUNDATION 2003-08-28 — — US disclosed
US-6586763-B2 Electroluminescent article comprising anode, plurality of molecular conductive layers coupled to one another and to anode with silicon-oxygen bonds, cathode, molecular charge control layer coupled with silicon-oxygen bonds NORTHWESTERN UNIVERSITY 2003-07-01 — — US disclosed
US-20020179898-A1 ORGANIC LIGHT-EMITTING DIODES AND METHODS FOR ASSEMBLY AND EMISSION CONTROL NATIONAL SCIENCE FOUNDATION 2002-12-05 — — US disclosed
US-6399221-B1 Organic light-emitting diodes and methods for assembly and emission control NORTHWESTERN UNIVERSITY 2002-06-04 — — US disclosed
US-6361885-B1 ANODES AND CATHODES FOR ELECTROLUMINESCENT DEVICE ORGANIC DISPLAY TECHNOLOGY 2002-03-26 — — US disclosed
US-5834100-A Organic light-emitting dioddes and methods for assembly and emission control NORTHWESTERN UNIVERSITY (US) 1998-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234256-A1 Organic light-emitting diodes and related hole transport compounds CLTB, SLCO4C1, ILK TOP1 2727/4885STAT3 2470/4885STAT1 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback